Montecito Bank & Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,942
Closed -$211K 288
2024
Q2
$211K Sell
1,942
-100
-5% -$11.8K 0.04% 251
2024
Q1
$270K Buy
2,042
+67
+3% +$8.37K 0.05% 241
2023
Q4
$240K Sell
1,975
-297
-13% -$33.1K 0.05% 236
2023
Q3
$255K Buy
2,272
+100
+5% +$12.7K 0.06% 213
2023
Q2
$316K Buy
2,172
+132
+6% +$17.9K 0.07% 202
2023
Q1
$264K Buy
2,040
+160
+9% +$20.1K 0.06% 211
2022
Q4
$240K Buy
+1,880
New +$218K 0.06% 224
2022
Q2
Sell
-1,947
Closed -$249K 268
2022
Q1
$249K Sell
1,947
-58
-3% -$6.99K 0.05% 243
2021
Q4
$248K Buy
2,005
+180
+10% +$23.6K 0.04% 243
2021
Q3
$260K Buy
1,825
+311
+21% +$45.7K 0.05% 240
2021
Q2
$237K Buy
+1,514
New +$245K 0.05% 239
2017
Q1
Sell
-1,066
Closed -$107K 378
2016
Q4
$107K Buy
+1,066
New +$114K 0.04% 218

Other funds holding ZBH

Montecito Bank & Trust's ZBH Position: Q3 2024 in Review

Montecito Bank & Trust sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 1,942 shares — an estimated $211K sold.

Montecito Bank & Trust first reported a position in ZBH in Q4 2016 and held it in 12 quarters. The position peaked at $316K in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Montecito Bank & Trust reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Montecito Bank & Trust sold 1,942 Zimmer Biomet shares in Q3 2024, an estimated $211K.
  • Montecito Bank & Trust first reported a position in Zimmer Biomet in Q4 2016 and held it in 12 quarters.
  • Montecito Bank & Trust's Zimmer Biomet position peaked at $316K in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Montecito Bank & Trust's 13F filing for Q3 2024, filed 31 Oct 2024.